GAL3ST3

galactose-3-O-sulfotransferase 3, the group of Sulfotransferases, membrane bound

Basic information

Region (hg38): 11:66040765-66049161

Links

ENSG00000175229NCBI:89792OMIM:608234HGNC:24144Uniprot:Q96A11AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the GAL3ST3 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the GAL3ST3 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
5
clinvar
5
missense
47
clinvar
1
clinvar
48
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
6
clinvar
6
Total 0 0 47 0 12

Variants in GAL3ST3

This is a list of pathogenic ClinVar variants found in the GAL3ST3 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
11-66042292-C-T Benign (Nov 11, 2018)1269158
11-66042404-C-A Benign (Nov 11, 2018)1223944
11-66042507-T-C Uncertain significance (Nov 03, 2019)993346
11-66042550-G-A not specified Uncertain significance (Nov 09, 2024)3518372
11-66042557-G-A not specified Uncertain significance (Feb 14, 2023)2483292
11-66042559-T-C not specified Uncertain significance (Feb 05, 2025)3852601
11-66042572-G-T not specified Uncertain significance (Jan 24, 2024)3098001
11-66042574-T-G Benign (Nov 11, 2018)1179723
11-66042577-G-A not specified Uncertain significance (Aug 22, 2023)2621488
11-66042578-G-A not specified Uncertain significance (Mar 08, 2025)3852607
11-66042580-C-A not specified Uncertain significance (Dec 28, 2024)3852604
11-66042581-G-A not specified Uncertain significance (Jan 02, 2025)3852602
11-66042593-C-T not specified Uncertain significance (Jul 27, 2021)3098000
11-66042596-C-T not specified Uncertain significance (Mar 20, 2024)3280491
11-66042598-C-T not specified Uncertain significance (Mar 31, 2023)2515737
11-66042604-T-G not specified Uncertain significance (Mar 24, 2023)2529190
11-66042610-T-G not specified Uncertain significance (Mar 24, 2023)2529744
11-66042638-C-T not specified Uncertain significance (Sep 27, 2024)3518370
11-66042641-C-T not specified Uncertain significance (Jan 29, 2024)3097999
11-66042689-C-T not specified Uncertain significance (Apr 15, 2024)3280492
11-66042703-T-C not specified Uncertain significance (Dec 15, 2023)3097998
11-66042724-C-G not specified Uncertain significance (Dec 14, 2024)3852600
11-66042738-C-T Benign (Nov 11, 2018)1293586
11-66042768-G-A Benign (Jun 09, 2021)1279065
11-66042788-C-T not specified Uncertain significance (Feb 14, 2025)2412582

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
GAL3ST3protein_codingprotein_codingENST00000312006 27229
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.93e-80.07381254740231254970.0000916
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.7742623000.8740.00002422698
Missense in Polyphen115126.640.908111180
Synonymous0.8581321450.9090.0000127943
Loss of Function-0.442119.531.154.09e-7114

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0003370.000332
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.0001470.000139
European (Non-Finnish)0.00009180.0000882
Middle Eastern0.000.00
South Asian0.00003320.0000327
Other0.0001650.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Transfers a sulfate to position 3 of non-reducing beta- galactosyl residues in N-glycans and core2-branched O-glycans. Has high activity towards Gal-beta-1,4-GlcNAc, Gal-beta-1,4(Fuc-alpha- 1,3)GlcNAc and lower activity towards Gal-beta-1,3(Fuc-alpha- 1,4)GlcNAc. {ECO:0000269|PubMed:11323440, ECO:0000269|PubMed:11356829}.;
Pathway
Metapathway biotransformation Phase I and II (Consensus)

Recessive Scores

pRec
0.110

Haploinsufficiency Scores

pHI
0.156
hipred
Y
hipred_score
0.544
ghis
0.551

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.201

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Gal3st3
Phenotype

Gene ontology

Biological process
monosaccharide metabolic process;sulfur compound metabolic process;glycolipid biosynthetic process;oligosaccharide metabolic process;proteoglycan biosynthetic process;poly-N-acetyllactosamine metabolic process
Cellular component
integral component of membrane;Golgi cisterna membrane
Molecular function
galactosylceramide sulfotransferase activity;carbohydrate binding;3'-phosphoadenosine 5'-phosphosulfate binding;galactose 3-O-sulfotransferase activity;proteoglycan sulfotransferase activity